Werewolf Therapeutics, Inc.
HOWL
$0.7998
-$0.0702-8.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -- | -85.86% | -83.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -- | -85.86% | -83.38% |
| Cost of Revenue | 2.49% | 82.64% | 15.59% | 59.36% | 2.65% |
| Gross Profit | -9.23% | -134.58% | -153.55% | -840.61% | -55.68% |
| SG&A Expenses | -3.60% | 3.68% | 6.64% | 5.85% | 18.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.49% | 40.69% | 13.04% | 42.09% | 7.29% |
| Operating Income | -4.83% | -56.98% | -85.10% | -212.51% | -40.41% |
| Income Before Tax | -11.71% | -69.96% | -101.24% | -238.35% | -35.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.71% | -69.96% | -101.24% | -238.35% | -35.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.71% | -69.96% | -101.24% | -238.35% | -35.14% |
| EBIT | -4.83% | -56.98% | -85.10% | -212.51% | -40.41% |
| EBITDA | -5.19% | -59.22% | -89.30% | -228.53% | -41.53% |
| EPS Basic | -3.67% | -39.76% | -64.16% | -176.36% | -12.98% |
| Normalized Basic EPS | -3.70% | -39.79% | -64.19% | -167.63% | -12.96% |
| EPS Diluted | -3.67% | -39.76% | -64.16% | -196.65% | -12.98% |
| Normalized Diluted EPS | -3.70% | -39.79% | -64.19% | -164.40% | -12.96% |
| Average Basic Shares Outstanding | 7.74% | 21.62% | 22.58% | 22.40% | 19.61% |
| Average Diluted Shares Outstanding | 7.74% | 21.62% | 22.58% | 23.86% | 19.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |